UCL researchers identify Huntington’s disease biomarker
Research led by scientists at UCL have identified the first blood test able to predict the onset and progression of Huntington’s disease (HD).
Read More
Tag: neurofilament
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
